These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21454380)

  • 1. Preventing endophthalmitis after cataract surgeries.
    Bellini LP; Martins GM; Bulla MC
    Br J Ophthalmol; 2011 Jun; 95(6):892-3; author reply 893. PubMed ID: 21454380
    [No Abstract]   [Full Text] [Related]  

  • 2. Endophthalmitis.
    Bohigian GM
    Ophthalmology; 2008 Feb; 115(2):413-4; author reply 414. PubMed ID: 18243911
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluoroquinolones and postoperative endophthalmitis.
    McCulley JP
    J Cataract Refract Surg; 2009 Feb; 35(2):206; author reply 207-9. PubMed ID: 19185216
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluoroquinolones and postoperative endophthalmitis.
    Lindstrom RL; Holland EJ; Lane SS
    J Cataract Refract Surg; 2009 Feb; 35(2):206-7; author reply 207-9. PubMed ID: 19185215
    [No Abstract]   [Full Text] [Related]  

  • 5. Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones: a retrospective observational case series.
    Moshirfar M; Feiz V; Vitale AT; Wegelin JA; Basavanthappa S; Wolsey DH
    Ophthalmology; 2007 Apr; 114(4):686-91. PubMed ID: 17184840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute endophthalmitis in eyes treated prophylactically with gatifloxacin and moxifloxacin.
    Deramo VA; Lai JC; Fastenberg DM; Udell IJ
    Am J Ophthalmol; 2006 Nov; 142(5):721-5. PubMed ID: 16989762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third- and fourth-generation fluoroquinolones: retrospective comparison of endophthalmitis after cataract surgery performed over 10 years.
    Jensen MK; Fiscella RG; Moshirfar M; Mooney B
    J Cataract Refract Surg; 2008 Sep; 34(9):1460-7. PubMed ID: 18721704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin.
    O'Brien TP; Arshinoff SA; Mah FS
    J Cataract Refract Surg; 2007 Oct; 33(10):1790-800. PubMed ID: 17889778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of moxifloxacin in the prophylaxis of post-surgical endophthalmitis].
    Villalobos PA; Valle DD
    Arch Soc Esp Oftalmol; 2010 Oct; 85(10):323-4. PubMed ID: 21168055
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery.
    Arbisser LB
    J Cataract Refract Surg; 2008 Jul; 34(7):1114-20. PubMed ID: 18571078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery.
    Lane SS; Osher RH; Masket S; Belani S
    J Cataract Refract Surg; 2008 Sep; 34(9):1451-9. PubMed ID: 18721703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical 0.5% moxifloxacin prevents endophthalmitis in an intravitreal injection rabbit model.
    Kowalski RP; Romanowski EG; Mah FS; Yates KA; Gordon YJ
    J Ocul Pharmacol Ther; 2008 Feb; 24(1):1-7. PubMed ID: 18370872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of prophylactic intracameral moxifloxacin use in cataract surgery.
    Ekinci Koktekir B; Aslan BS
    J Ocul Pharmacol Ther; 2012 Jun; 28(3):278-82. PubMed ID: 22304496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of aqueous humor concentrations of fluoroquinolones.
    Scassellati Sforzolini B; Sheets JW; Morris TW
    J Cataract Refract Surg; 2011 Jan; 37(1):217-8. PubMed ID: 21183123
    [No Abstract]   [Full Text] [Related]  

  • 15. Intracameral Vigamox (moxifloxacin 0.5%) is not effective in preventing endophthalmitis in a rabbit model.
    Kodjikian L; Garweg JG
    Am J Ophthalmol; 2006 Apr; 141(4):777; author reply 777-8. PubMed ID: 16564833
    [No Abstract]   [Full Text] [Related]  

  • 16. Endophthalmitis prophylaxis.
    Ou JI; Ta CN
    Ophthalmol Clin North Am; 2006 Dec; 19(4):449-56. PubMed ID: 17067900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endophthalmitis Reduction with Intracameral Moxifloxacin Prophylaxis: Analysis of 600 000 Surgeries.
    Haripriya A; Chang DF; Ravindran RD
    Ophthalmology; 2017 Jun; 124(6):768-775. PubMed ID: 28214101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic considerations for cataract surgery.
    Tipperman R
    Curr Opin Ophthalmol; 2004 Feb; 15(1):51-5. PubMed ID: 14743020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic choice for the prophylaxis of post-cataract extraction endophthalmitis.
    Rudnisky CJ; Wan D; Weis E
    Ophthalmology; 2014 Apr; 121(4):835-41. PubMed ID: 24326107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients.
    Espiritu CR; Caparas VL; Bolinao JG
    J Cataract Refract Surg; 2007 Jan; 33(1):63-8. PubMed ID: 17189795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.